We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 3,320

Massachusetts Court Weighs in on Product Hopping Allegations and Reverse Payment Standing
  • McDermott Will & Emery
  • USA
  • November 11 2016

Addressing a motion to dismiss a bevy of antitrust allegations, the US District Court for the District of Massachusetts held that a class of


Supreme Court Will Not Review Pay-For-Delay Case over GSK’s Lamictal
  • Knobbe Martens Olson & Bear LLP
  • USA
  • November 11 2016

On November 7, 2016, the U.S. Supreme Court declined to review an appeal from a Third Circuit decision finding that a settlement between


Payer Support for Provider Mergers: The Importance of Being Proactive
  • Squire Patton Boggs
  • USA
  • November 11 2016

Health care providers are undergoing a merger wave. In part due to incentives created by the Affordable Care Act, more and more providers are


Northern District of California Dismisses Claims that Gilead Violated the Antitrust Laws in Seeking to Protect its Position on HIV Drug
  • McDermott Will & Emery
  • USA
  • November 11 2016

Ruling on a motion to dismiss, the US District Court for the Northern District of California dismissed AIDS Healthcare's antitrust claims alleging


Second Circuit: No Valid Sherman Act Claim Where Citizen Petition Denied Contemporaneously with ANDA Approval
  • McDermott Will & Emery
  • USA
  • November 11 2016

The US Court of Appeals for the Second Circuit held that a pharmaceutical manufacturer failed to state a Sherman Act Section Two claim because the


Two reverse-payment appeals to watch
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • November 10 2016

It has been over three years since the Supreme Court’s Actavis decision. Since then, numerous putative class actions alleging harm to competition as a


Seventh Circuit Hands FTC Another Geographic Market Definition Victory in Chicago Hospital Merger Case
  • McDermott Will & Emery
  • USA
  • November 9 2016

On October 31, 2016, the US Court of Appeals for the Seventh Circuit handed another important victory to the Federal Trade Commission (FTC) and the


FTC's Winning Streak Restored: Seventh Circuit Reverses Denial of Preliminary Injunction in Chicago Hospital Merger
  • Pepper Hamilton LLP
  • USA
  • November 8 2016

Recent appellate decisions confirm the uphill battle hospitals face when merging with other hospitals. On October 31, the U.S. Court of Appeals for


Special Masters in Health Care Antitrust Merger Cases: Resolving the Conflicting Interests
  • JAMS
  • USA
  • November 8 2016

One of the most challenging aspects of antitrust cases in the health care field is the rich mixture of public interest considerations, pro-competitive


Washington Healthcare Update - November 7th, 2016
  • McGuireWoods LLP
  • USA
  • November 7 2016

In a Nov. 3 letter, Reps. Diana DeGette (D-CO) and Susan Brooks (R-ID), both members of the House Energy and Commerce Committee, asked the Food and